Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel poliglumex, work in different ways
to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Estradiol may kill prostate cancer cells that no longer respond to hormone therapy.
Giving paclitaxel poliglumex together with estradiol may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving paclitaxel poliglumex together with
estradiol works in treating patients with stage IV prostate cancer.